근시의 약물치료

• 영문명: Medical Treatment of Progression of Myopia
• 발행기관: 대한검안학회
• 저자명: 김응수(Ungsoo Samuel Kim)
• 간행물 정보: 『Annals of optometry and contact lens』Vol.17 No.1, 1~4쪽, 전체 4쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2018.03.30

영문 초록

The prevalence of myopia is up to 80% in young Korean population. The myopia can develop serious complications such as choroidal neovascularization, retinal detachment and glaucoma. As a result, several studies to prevent progression of myopia have been conducted. Among them, muscarinic antagonists are the more effective at slowing progression than other methods including orthokeratology and designed glasses. Recent studies have reported that low-dose atropine is also effective to slow progression of the myopia and it has fewer complications than high-dose atropine. However, long term side effect has not been clarified, and the commercial low-dose atropine is not available currently in Korea. Thus, in-depth studies about low-dose atropine should be considered.

목차

서 론

본 론

결 론

REFERENCES

키워드

Atropine Muscarine antagonist Myopia